139 related articles for article (PubMed ID: 8770177)
1. Insulin-like growth factor-I action on glucose transport in acute renal failure.
Mak RH; Mehls O
Am J Physiol; 1996 Aug; 271(2 Pt 2):F440-5. PubMed ID: 8770177
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance but IGF-I sensitivity in chronic renal failure.
Mak RH
Am J Physiol; 1996 Jul; 271(1 Pt 2):F114-9. PubMed ID: 8760251
[TBL] [Abstract][Full Text] [Related]
3. Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal.
Hawkins M; Barzilai N; Chen W; Angelov I; Hu M; Cohen P; Rossetti L
Diabetes; 1996 Dec; 45(12):1734-43. PubMed ID: 8922359
[TBL] [Abstract][Full Text] [Related]
4. IGF-I binding proteins, IGF-I binding protein mRNA and IGF-I receptor mRNA in rats with acute renal failure given IGF-I.
Bohé J; Ding H; Qing DP; Yoon K; Hirschberg R; Wolfgang GH; Kopple JD
Kidney Int; 1998 Oct; 54(4):1070-82. PubMed ID: 9767523
[TBL] [Abstract][Full Text] [Related]
5. Effects of insulin-like growth factor I on glucose metabolism in rats with liver cirrhosis.
Petersen KF; Jacob R; West AB; Sherwin RS; Shulman GI
Am J Physiol; 1997 Dec; 273(6):E1189-93. PubMed ID: 9435535
[TBL] [Abstract][Full Text] [Related]
6. Effects of recombinant human IGF-I on glucose and leucine kinetics in men.
Elahi D; McAloon-Dyke M; Fukagawa NK; Sclater AL; Wong GA; Shannon RP; Minaker KL; Miles JM; Rubenstein AH; Vandepol CJ
Am J Physiol; 1993 Dec; 265(6 Pt 1):E831-8. PubMed ID: 8279537
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous insulinlike growth factor I and insulin resistance in obese Zucker rats.
Jacob RJ; Sherwin RS; Greenawalt K; Shulman GI
Diabetes; 1992 Jun; 41(6):691-7. PubMed ID: 1587396
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans.
Laager R; Ninnis R; Keller U
J Clin Invest; 1993 Oct; 92(4):1903-9. PubMed ID: 8408642
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I improves glucose utilization in tumor necrosis factor-treated rats under hyperinsulinemic-euglycemic conditions.
Ling PR; Sierra P; Qu Z; Bistrian BR
Metabolism; 1997 Sep; 46(9):1052-8. PubMed ID: 9284895
[TBL] [Abstract][Full Text] [Related]
10. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.
Pratipanawatr T; Pratipanawatr W; Rosen C; Berria R; Bajaj M; Cusi K; Mandarino L; Kashyap S; Belfort R; DeFronzo RA
Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1360-8. PubMed ID: 12006367
[TBL] [Abstract][Full Text] [Related]
11. Metabolic effects of IGF-I and insulin in spontaneously diabetic BB/w rats.
Jacob RJ; Sherwin RS; Bowen L; Fryburg D; Fagin KD; Tamborlane WV; Shulman GI
Am J Physiol; 1991 Feb; 260(2 Pt 1):E262-8. PubMed ID: 1996629
[TBL] [Abstract][Full Text] [Related]
12. Preserved hypothermic response to hypoglycemia after antecedent hypoglycemia.
Fruehwald-Schultes B; Kern W; Dantz D; Born J; Fehm HL; Peters A
Metabolism; 2000 Jun; 49(6):794-8. PubMed ID: 10877209
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I and insulin have no differential effects on glucose production and utilization under conditions of hyperglycemia.
Giacca A; Fisher SJ; Shi ZQ; Gupta R; Lickley HL; Skottner A; Anderson GH; Efendic S; Vranic M
Endocrinology; 1994 May; 134(5):2251-8. PubMed ID: 8156929
[TBL] [Abstract][Full Text] [Related]
14. Acute effects of insulin-like growth factor I and insulin on glucose metabolism in vivo.
Moxley RT; Arner P; Moss A; Skottner A; Fox M; James D; Livingston JN
Am J Physiol; 1990 Oct; 259(4 Pt 1):E561-7. PubMed ID: 2221058
[TBL] [Abstract][Full Text] [Related]
15. High dosage growth hormone treatment and post-ischemic acute renal failure in the rat.
Matejka GL; Bengtsson BA
Growth Horm IGF Res; 1998 Apr; 8(2):151-7. PubMed ID: 10987682
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of IGF-I in diabetic rats.
Rossetti L; Frontoni S; Dimarchi R; DeFronzo RA; Giaccari A
Diabetes; 1991 Apr; 40(4):444-8. PubMed ID: 2010044
[TBL] [Abstract][Full Text] [Related]
17. A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans.
Hartman ML; Clayton PE; Johnson ML; Celniker A; Perlman AJ; Alberti KG; Thorner MO
J Clin Invest; 1993 Jun; 91(6):2453-62. PubMed ID: 8514857
[TBL] [Abstract][Full Text] [Related]
18. Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin.
Jacob R; Barrett E; Plewe G; Fagin KD; Sherwin RS
J Clin Invest; 1989 May; 83(5):1717-23. PubMed ID: 2651479
[TBL] [Abstract][Full Text] [Related]
19. Central insulin-like growth factor-1 (IGF-1) restores whole-body insulin action in a model of age-related insulin resistance and IGF-1 decline.
Huffman DM; Farias Quipildor G; Mao K; Zhang X; Wan J; Apontes P; Cohen P; Barzilai N
Aging Cell; 2016 Feb; 15(1):181-6. PubMed ID: 26534869
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-I inhibits insulin and amylin secretion in conscious rats.
Fürnsinn C; Alma M; Roden M; Pieber T; Nowotny P; Schneider B; Waldhäusl W
Endocrinology; 1994 Nov; 135(5):2144-9. PubMed ID: 7956938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
